Multiomics profiling of the therapeutic effect of Dan-deng-tong-nao capsule on cerebral ischemia-reperfusion injury

Shi, Yingying; Du, Qiuzheng; Li, Zhuolun; Xue, Lianping; Jia, Qingquan; Zheng, Tianyuan; Liu, Jiyun; Ren, Ruobing; Sun, Zhi

doi:10.1016/j.phymed.2023.155335

Cited by 1 publication

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To date, several pioneering researchers have investigated the regulatory mechanism of TCM formulations on ferroptosis using omics methodologies. This has marked a transition in TCM research from the traditional "one-target, one-drug" model to a "multi-target, multi-component" framework (Ding et al, 2021;Liu et al, 2021;Chen J. et al, 2023;Liu S. et al, 2023;Wang Y. et al, 2023;Wang et al, 2023d;Gu et al, 2023;Qin et al, 2023;Wu et al, 2023;Bai et al, 2024;Shi et al, 2024).…”

Section: Multi-omicsmentioning

confidence: 99%

Targeting ferroptosis unveils a new era for traditional Chinese medicine: a scientific metrology study

Cao,

Wei,

Yue

et al. 2024

Front. Pharmacol.

View full text Add to dashboard Cite

In the past 11 years, there has been a surge in studies exploring the regulatory effect of Traditional Chinese Medicine (TCM) on ferroptosis. However, a significant gap persists in comprehensive scientometric analysis and scientific mapping research, especially in tracking the evolution, primary contributors, and emerging research focal points. This study aims to comprehensively update the advancements in targeting ferroptosis with various TCMs during the previous 11 years. The data, covering the period from 1 January 2012, to 30 November 2023, were retrieved from the Web of Science database. For in-depth scientometric and visualized analyses, a series of advanced analytical instruments were employed. The findings highlight China’s predominant role, accounting for 71.99% of total publications and significantly shaping research in this domain. Noteworthy productivity was observed at various institutions, including Guangzhou University of Chinese Medicine, Chengdu University of Traditional Chinese Medicine, and Zhejiang University. Thomas Efferth emerged as the foremost author within this field, while Frontiers in Pharmacology boasted the highest publication count. This study pinpointed hepatocellular carcinoma, chemical and drug-induced liver injury, mitochondrial diseases, acute kidney injury, and liver failure as the most critical disorders addressed in this research realm. The research offers a comprehensive bibliometric evaluation, enhancing our understanding of the present status of TCM therapy in managing ferroptosis-related diseases. Consequently, it aids both seasoned researchers and newcomers by accelerating access to vital information and fostering innovative concept extraction within this specialized field.

show abstract